Prosthesis (i.e. – artificial body members) – parts thereof – or ai – Arterial prosthesis – Stent combined with surgical delivery system
Reexamination Certificate
1999-01-15
2002-02-26
O'Connor, Cary E. (Department: 3731)
Prosthesis (i.e., artificial body members), parts thereof, or ai
Arterial prosthesis
Stent combined with surgical delivery system
Reexamination Certificate
active
06350277
ABSTRACT:
BACKGROUND OF THE INVENTION
This invention relates specifically to stents but also generally to any expandable, implantable endoprosthesis such as grafts, stent-grafts and the like. When the term ‘stent’ is used herein, it is to be understood in a general sense as including all such expandable prostheses, unless otherwise indicated.
The use of endoprostheses such as stents, stent-grafts and grafts is well known in maintaining the patency of bodily vessels including blood vessels and biliary ducts. Typically, an endoprosthesis is implanted in a vessel which has been occluded, which is subject to an aneurysm, which has a lesion present or is otherwise damaged. Often, during the implantation of the endoprosthesis, the vessel will suffer from trauma. The trauma may be as a result of the dilation prior to the implantation of the endoprosthesis, the presence of a foreign body (the endoprosthesis) in the bodily vessel or as a result of other causes. Regardless of the source of the trauma, the vessel may be in a weakened and inflamed state as a result of implantation of the endoprosthesis. Although it is desirable to maintain the vessel at as large a diameter as possible to minimize the possibility of restenosis, the weakening of the vessel resulting from the trauma limits the extent to which the vessel can be dilated.
The endoprostheses that are currently available are typically balloon expandable, self-expanding, or balloon assisted self-expanding devices. Balloon expandable stents achieve their maximum diameter upon expansion by a balloon. Once they have been seated in the vessel, they are incapable of further expansion unless a balloon is reinserted in the stent and expanded. Self-expanding and balloon assisted expandable stents, on the other hand, continually exert an outward force as they try to attain their maximum possible diameter. Thus, even after the stent is implanted, if it has not reached its maximum diameter it continues to try to open further exerting a force on the vessel walls.
It would be desirable to provide an endoprosthesis which has some of the characteristics of balloon expandable stents following deployment and which has some of the properties of self-expanding stents after a predetermined period of time or after the application of a predetermined amount of force thereto. In particular, it is desirable to provide an endoprosthesis which does not impart to the vessel walls the outward forces associated with a self-expanding stent while the vessel is recovering from the trauma of the deployment procedure and yet provides the outward expanding force of a self-expanding stent when the vessel is sufficiently recovered from the trauma.
It is also desirable to provide an endoprosthesis which only partially expands or does not expand at all during deployment and which expands at some later point following deployment.
The present invention provides such an endoprosthesis.
For the purposes of this disclosure, unless otherwise indicated, the term ‘degradation’ shall refer to degradation in its ordinary sense as well as biodegradation, erosion, and dissolution.
BRIEF SUMMARY OF THE INVENTION
The invention is directed to an expandable stent comprising an expandable stent framework which is expandable from a reduced diameter configuration to a fully expanded configuration. At least one stent retaining segment which is constructed to fail is disposed about the stent framework to maintain the stent framework in a reduced diameter state until the retaining segment fails. The retaining segment may be constructed to fail after a predetermined period of time has elapsed and/or after a predetermined amount of force has been applied to the stent. The retaining segment may be entirely biodegradable, biodegradable in part, erodible or made of an inert material with fatigue points.
In one embodiment of the invention, the retaining segment forms a band around the outside of the stent or interwoven about the stent. In particular, the retaining segment may be woven such that it alternates on the inner and outer strut surfaces.
The retaining segment may also be provided in the form of a web.
The invention is also directed to treatment methods in which the inventive stent is deployed and further expands upon failure of the retaining segments. In the case of an inert segment, failure of the retaining segment may result from mechanical failure. Stresses on the stent which are likely to result in or contribute to the desired failure include pulsing blood pressure which is thought to cause an alternating lengthening and shortening of the stent.
In the case of a biodegradable segment or an erodible segment, failure results from degradation or erosion of the segment. Finally, in the case of a segment made of inert material and connecting dots of biodegradable material, failure results from degradation or erosion of the connecting dots.
More generally, the invention is directed to the application of a secondary increased expansive force to a body lumen by an implantable expandable medical device such as a stent endoprostheses including stents, stent-grafts, grafts and vena cava filters at a predetermined time following implantation into a body lumen.
REFERENCES:
patent: 3105492 (1963-10-01), Jeckel
patent: 3272204 (1966-09-01), Artandi et al.
patent: 3304557 (1967-02-01), Polansky
patent: 3463158 (1969-08-01), Schmitt et al.
patent: 3479670 (1969-11-01), Medell
patent: 3878565 (1975-04-01), Sauvage
patent: 3993078 (1976-11-01), Bergentz et al.
patent: 4610688 (1986-09-01), Silvestrini et al.
patent: 4655771 (1987-04-01), Wallsten
patent: 4731073 (1988-03-01), Robinson
patent: 4743251 (1988-05-01), Barra
patent: 4954126 (1990-09-01), Wallstèn
patent: 5061275 (1991-10-01), Wallstèn et al.
patent: 5064435 (1991-11-01), Porter
patent: 5123917 (1992-06-01), Lee
patent: 5192307 (1993-03-01), Wall
patent: 5234457 (1993-08-01), Andersen
patent: 5330500 (1994-07-01), Song
patent: 5383926 (1995-01-01), Lock et al.
patent: 5405377 (1995-04-01), Cragg
patent: 5405378 (1995-04-01), Strecker
patent: 5433723 (1995-07-01), Lindenberg et al.
patent: 5445646 (1995-08-01), Euteneuer et al.
patent: 5476508 (1995-12-01), Amstrup
patent: 5534007 (1996-07-01), St. Germain et al.
patent: 5556413 (1996-09-01), Lam
patent: 5571135 (1996-11-01), Fraser et al.
patent: 5632840 (1997-05-01), Campbell
patent: 5670161 (1997-09-01), Healy et al.
patent: 5779732 (1998-07-01), Amundson
patent: 5830217 (1998-11-01), Ryan
patent: RE35988 (1998-12-01), Winston et al.
patent: 5843158 (1998-12-01), Lenker et al.
patent: 5849037 (1998-12-01), Frid
patent: 5871537 (1999-02-01), Holman et al.
patent: 5873906 (1999-02-01), Lau et al.
patent: 5873907 (1999-02-01), Frantzen
patent: 5899935 (1999-05-01), Ding
patent: 5957975 (1999-09-01), Lafont et al.
patent: 5972029 (1999-10-01), Fuisz
patent: 5989280 (1999-11-01), Euteneuer et al.
patent: 0 382 014 (1990-01-01), None
patent: 88/00813 (1988-11-01), None
patent: 98/11846 (1998-03-01), None
O'Connor Cary E.
Sci-Med Life Systems, Inc.
Vidas Arrett & Steinkraus
LandOfFree
Stents with temporary retaining bands does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Stents with temporary retaining bands, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stents with temporary retaining bands will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2983952